Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shan Fu

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
Nature Medicine|September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialJingjing Feng, Dawei Huo, Ruimin Hong, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaChunxiang Jin, Rongrong Chen, Shan Fu, et al.
Journal of Advanced Research|February 13, 2025
Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up resultTingting Yang, Yetian Dong, Jimin Shi, et al.
British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.
Frontiers in Oncology|November 1, 2021
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3<sup>+</sup> T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome PatientsYan Huang, Minghua Hong, Zhigang Qu, et al.
JAMA Oncology|April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical TrialMingming Zhang, Shan Fu, Jingjing Feng, et al.
The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
Nature Medicine|September 24, 2025
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trialJingjing Feng, Dawei Huo, Ruimin Hong, et al.
Journal for Immunotherapy of Cancer|March 28, 2025
Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myelomaChunxiang Jin, Rongrong Chen, Shan Fu, et al.
Journal of Advanced Research|February 13, 2025
Sequential allogeneic HSCT after CAR-T therapy for relapsed/refractory acute lymphoblastic leukemia patients: A long-term follow-up resultTingting Yang, Yetian Dong, Jimin Shi, et al.
British Journal of Haematology|May 16, 2023
Derivation and validation of a novel score for early prediction of severe CRS after CAR-T therapy in haematological malignancy patients: A multi-centre studyLinghui Zhou, Weijun Fu, Shenghao Wu, et al.
Frontiers in Oncology|November 1, 2021
Non-Ablative Chemotherapy Followed by HLA-Mismatched Allogeneic CD3<sup>+</sup> T-Cells Infusion Causes An Augment of T-Cells With Mild CRS: A Multi-Centers Single-Arm Prospective Study on Elderly Acute Myeloid Leukemia and int-2/High Risk Myelodysplastic Syndrome PatientsYan Huang, Minghua Hong, Zhigang Qu, et al.
JAMA Oncology|April 17, 2025
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical TrialMingming Zhang, Shan Fu, Jingjing Feng, et al.
The New England Journal of Medicine|April 24, 2024
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD ProphylaxisYongxian Hu, Mingming Zhang, Tingting Yang, et al.
Pageof 27